1. DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA. Issue 2 (22nd June 2018) Authors: Mount, Christopher; Majzner, Robbie; Sundaresh, Shree; Arnold, Evan; Kadapakkam, Meena; Haile, Samuel; Labanieh, Louai; Woo, Pamelyn; Rietberg, Skyler; Vogel, Hannes; Monje, Michelle; Mackall, Crystal Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas. (May 2018) Authors: Mount, Christopher; Majzner, Robbie; Sundaresh, Shree; Arnold, Evan; Kadapakkam, Meena; Haile, Samuel; Labanieh, Louai; Hulleman, Esther; Woo, Pamelyn; Rietberg, Skyler; Vogel, Hannes; Monje, Michelle; Mackall, Crystal Journal: Nature medicine Issue: Volume 24:Number 5(2018) Page Start: 572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Utility of preoperative laboratory evaluation in low-risk patients undergoing hysterectomy for benign indications. (May 2020) Authors: Sears, Sarah; Mangel, Jeffrey; Adedayo, Pelumi; Mims, Joseph; Sundaresh, Shree; Sheyn, David Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 248(2020) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗